View ValuationSyncona 将来の成長Future 基準チェック /06現在、 Synconaの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Capital Markets 収益成長11.2%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • May 29Syncona Limited to Report Fiscal Year 2026 Results on Jun 18, 2026Syncona Limited announced that they will report fiscal year 2026 results on Jun 18, 2026お知らせ • Aug 08Syncona Limited Announces Board ChangesSyncona Limited announced, following its Annual General Meeting (AGM), Virginia Holmes has retired from the Board. Kemal Malik will take up the role of Senior Independent Director, effective immediately. He joined the Syncona Board in 2020, bringing 30 years of experience in global pharmaceutical research and development. In line with the Company's strategy update on 19 June 2025, in the event a new investment objective and policy, is approved by shareholders, the Company would expect to reduce the size of the Board for the new strategy.お知らせ • Jul 02Syncona Limited, Annual General Meeting, Aug 05, 2025Syncona Limited, Annual General Meeting, Aug 05, 2025.お知らせ • Dec 12Syncona Limited to Report Q3, 2025 Results on Feb 06, 2025Syncona Limited announced that they will report Q3, 2025 results on Feb 06, 2025お知らせ • Nov 19Syncona Limited Announces Step Down of Gian Piero Reverberi as Member of Its Board Audit CommitteeSyncona Limited announced the following board committee change: Following a review of board committee composition, Gian Piero Reverberi will step down as a member of the company's board audit committee with immediate effect.お知らせ • Oct 23Syncona Limited to Report Fiscal Year 2025 Results on Jun 19, 2025Syncona Limited announced that they will report fiscal year 2025 results on Jun 19, 2025お知らせ • Sep 20Syncona Limited Announces Appointment of John Roche as an Independent Non-Executive Director, Effective from 1 October 2024Syncona Limited announced the appointment of John Roche as an independent Non-Executive Director, with effect from 1 October 2024. John brings many years of broad financial experience to the role, having spent more than 15 years as a Partner at PricewaterhouseCoopers in Guernsey. During this time he served as managing partner of the Guernsey office for seven years and was leader of the Capital Markets Practice for twelve years. While at PwC, John specialised in providing audit and capital markets advisory services to listed investment companies and alternative asset management clients, developing extensive valuation experience. John is a Fellow of the Institute of Chartered Accountants in Ireland, who retired from practice in 2022. He is a Non-Executive Director and Chair of the Audit Committee of Riverstone Energy Limited, and a Guernsey resident. On appointment, John will join the Company's Audit Committee.お知らせ • Jul 05Syncona Limited, Annual General Meeting, Aug 06, 2024Syncona Limited, Annual General Meeting, Aug 06, 2024. Location: the offices of citco fund services, guernsey limited, frances house, sir william place, United Kingdomお知らせ • Jun 26Syncona Limited to Report Q1, 2025 Results on Aug 15, 2024Syncona Limited announced that they will report Q1, 2025 results on Aug 15, 2024お知らせ • Jun 21Syncona Limited to Report First Half, 2025 Results on Nov 14, 2024Syncona Limited announced that they will report first half, 2025 results on Nov 14, 2024お知らせ • Jan 05Syncona Limited to Report Q3, 2024 Results on Feb 08, 2024Syncona Limited announced that they will report Q3, 2024 results on Feb 08, 2024お知らせ • Nov 15Syncona Limited to Report Fiscal Year 2024 Results on Jun 20, 2024Syncona Limited announced that they will report fiscal year 2024 results on Jun 20, 2024お知らせ • Oct 19Syncona Seeks to Buy Remaining Shares of Freeline TherapeuticsSyncona Limited (LSE:SYNC) that its investment manager has submitted a proposal to buy the shares of Freeline Therapeutics Holdings plc (NasdaqCM:FRLN) that it doesn't already own, and plans to start talks with the company over a potential deal. The U.K. healthcare company said Wednesday that it is offering to pay $5.00 for each American Depositary Share of Freeline, a 20% premium over the volume weighted average price of $4.16 between Oct. 4 and Oct. 16. Syncona, which currently owns approximately 57.9% of Freeline, said there isn't a guarantee that any deal will be agreed. Syncona shares at 10:30 GMT were up 0.20 pence, or 0.2%, at 126.20 pence.お知らせ • Jun 29Syncona Limited to Report First Half, 2024 Results on Nov 16, 2023Syncona Limited announced that they will report first half, 2024 results on Nov 16, 2023お知らせ • Jun 28Syncona Limited, Annual General Meeting, Aug 01, 2023Syncona Limited, Annual General Meeting, Aug 01, 2023, at 09:30 Coordinated Universal Time. Location: Citco Fund Services (Guernsey) Limited, Frances House, Sir William Place, St Peter Port, Guernsey GY1 1GX Guernsey United Kingdom Agenda: To consider The Directors must lay the annual audited accounts for the financial year ended 31 March 2023 and the reports of the Directors and Auditors before the Shareholders and the Shareholders will be asked to receive and consider the financial statements and the reports; to consider Shareholders will be asked to confirm the reappointment of Deloitte LLP (Guernsey Branch) as Auditors until the conclusion of the next annual general meeting due to be held in 2024 and to grant authority to the Board to determine their remuneration; and to transact such other business matter.お知らせ • Dec 07Syncona Limited to Report Q3, 2023 Results on Feb 07, 2023Syncona Limited announced that they will report Q3, 2023 results on Feb 07, 2023お知らせ • Aug 09Syncona Limited to Report Q1, 2023 Results on Aug 16, 2022Syncona Limited announced that they will report Q1, 2023 results on Aug 16, 2022お知らせ • Aug 03Syncona Limited Approves Appointment of Julie Cherrington and Cristina Csimma as DirectorSyncona Limited at the AGM held on June 30, 2022 approved the appointment of Julie Cherrington as a Director and Cristina Csimma as a Director.お知らせ • Jul 15Syncona Limited to Report First Half, 2023 Results on Nov 17, 2022Syncona Limited announced that they will report first half, 2023 results on Nov 17, 2022お知らせ • Jul 01Syncona Limited, Annual General Meeting, Aug 02, 2022Syncona Limited, Annual General Meeting, Aug 02, 2022, at 09:30 Coordinated Universal Time. Location: Citco Fund Services (Guernsey) Limited, Arnold House St Julian’s Avenue, St Peter Port Guernsey United Kingdom Agenda: To consider that the Annual Audited Financial Statements of the Company for the year ended 31 March 2022, together with the reports of the Directors and Auditors therein, be received and considered; to consider that Deloitte LLP (Guernsey Branch) be re-appointed as Auditors until the conclusion of the next annual general meeting; to consider that the Board of Directors be authorized to determine the remuneration of the Auditors; to consider that Melanie Gee be re-elected as a Director; to consider that Julie Cherrington be elected as a Director; and to consider other matters.お知らせ • Apr 01Syncona Limited to Report Fiscal Year 2022 Results on Jun 16, 2022Syncona Limited announced that they will report fiscal year 2022 results on Jun 16, 2022お知らせ • Feb 12Syncona Limited Appoints Richard Francis as Chief Executive OfficerSyncona Limited appointed of Richard Francis, former Chief Executive of Sandoz and former member of Novartis Executive Committee, as Chief Executive Officer.お知らせ • Feb 11Syncona Limited Decides to Reduce Its Overall Headcount by Approximately 20%Syncona Limited announced took decisive action in First Quarter 2021 to reduce its overall headcount by approximately 20%, realising cost savings, on an annualised basis, of approximately $15 million once the operational changes are fully implemented.お知らせ • Dec 23Syncona Limited Appoints Virginia Holmes as A Non-Executive Director with Effect from 1 January 2021Syncona Ltd. announced the appointment of Virginia Holmes as a Non-Executive Director with effect from 1 January 2021.お知らせ • Nov 19Syncona Limited Does Not Declare DividendDuring the period ended 30 September 2020, the Syncona Limited did not declare or pay a dividend (30 September 2019: £15,208,113, 31 March 2020: £15,208,113). The Directors believe that it is no longer appropriate for the Group to pay a dividend.お知らせ • Nov 03Syncona Ltd Announces Retirement of Ellen Strahlman as Non-Executive Director with Effect from November 2, 2020Syncona Ltd. announces retirement of Ellen Strahlman as Non-Executive Director with effect from November 2, 2020. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Syncona は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測BATS-CHIXE:SYNCL - アナリストの将来予測と過去の財務データ ( )GBP Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数9/30/2025-67-943030N/A6/30/2025-94-1183737N/A3/31/2025-121-1434444N/A12/31/2024-58-804242N/A9/30/20246-184040N/A6/30/202418-73030N/A3/31/20243142020N/A12/31/2023-57-811010N/A9/30/2023-144-16500N/A6/30/2023-92-11100N/A3/31/2023-40-5600N/A12/31/2022957800N/A9/30/2022230212-1-1N/A6/30/202212411100N/A3/31/202219900N/A12/31/2021-92-10300N/A9/30/2021-203-21500N/A6/30/2021-62-8100N/A3/31/2021795300N/A12/31/2020714100N/A9/30/2020633011N/A6/30/2020-52-8377N/A3/31/2020-167-1961313N/A12/31/2019-94-1201414N/A9/30/2019-21-441616N/A6/30/2019209184N/A14N/A3/31/2019439411N/A11N/A12/31/2018421393N/A8N/A9/30/2018404374N/A4N/A6/30/2018300273N/A6N/A3/31/2018196173N/A8N/A12/31/2017209189N/A11N/A9/30/2017221206N/A13N/A6/30/2017153142N/A10N/A3/31/20178677N/A7N/A12/31/20166456N/A7N/A9/30/20164235N/A7N/A6/30/20162317N/A6N/A3/31/20165-1N/A6N/A12/31/20152115N/A6N/A9/30/20153731N/A6N/A6/30/20154640N/A6N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: SYNCLの予測収益成長が 貯蓄率 ( 3.4% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: SYNCLの収益がUK市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: SYNCLの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: SYNCLの収益がUK市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: SYNCLの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: SYNCLの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分ですView Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/09 12:34終値2026/06/09 00:00収益2025/09/30年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Syncona Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Kane SlutzkinDeutsche BankPaul CuddonDeutsche BankKenneth RumphJefferies LLC1 その他のアナリストを表示
お知らせ • May 29Syncona Limited to Report Fiscal Year 2026 Results on Jun 18, 2026Syncona Limited announced that they will report fiscal year 2026 results on Jun 18, 2026
お知らせ • Aug 08Syncona Limited Announces Board ChangesSyncona Limited announced, following its Annual General Meeting (AGM), Virginia Holmes has retired from the Board. Kemal Malik will take up the role of Senior Independent Director, effective immediately. He joined the Syncona Board in 2020, bringing 30 years of experience in global pharmaceutical research and development. In line with the Company's strategy update on 19 June 2025, in the event a new investment objective and policy, is approved by shareholders, the Company would expect to reduce the size of the Board for the new strategy.
お知らせ • Jul 02Syncona Limited, Annual General Meeting, Aug 05, 2025Syncona Limited, Annual General Meeting, Aug 05, 2025.
お知らせ • Dec 12Syncona Limited to Report Q3, 2025 Results on Feb 06, 2025Syncona Limited announced that they will report Q3, 2025 results on Feb 06, 2025
お知らせ • Nov 19Syncona Limited Announces Step Down of Gian Piero Reverberi as Member of Its Board Audit CommitteeSyncona Limited announced the following board committee change: Following a review of board committee composition, Gian Piero Reverberi will step down as a member of the company's board audit committee with immediate effect.
お知らせ • Oct 23Syncona Limited to Report Fiscal Year 2025 Results on Jun 19, 2025Syncona Limited announced that they will report fiscal year 2025 results on Jun 19, 2025
お知らせ • Sep 20Syncona Limited Announces Appointment of John Roche as an Independent Non-Executive Director, Effective from 1 October 2024Syncona Limited announced the appointment of John Roche as an independent Non-Executive Director, with effect from 1 October 2024. John brings many years of broad financial experience to the role, having spent more than 15 years as a Partner at PricewaterhouseCoopers in Guernsey. During this time he served as managing partner of the Guernsey office for seven years and was leader of the Capital Markets Practice for twelve years. While at PwC, John specialised in providing audit and capital markets advisory services to listed investment companies and alternative asset management clients, developing extensive valuation experience. John is a Fellow of the Institute of Chartered Accountants in Ireland, who retired from practice in 2022. He is a Non-Executive Director and Chair of the Audit Committee of Riverstone Energy Limited, and a Guernsey resident. On appointment, John will join the Company's Audit Committee.
お知らせ • Jul 05Syncona Limited, Annual General Meeting, Aug 06, 2024Syncona Limited, Annual General Meeting, Aug 06, 2024. Location: the offices of citco fund services, guernsey limited, frances house, sir william place, United Kingdom
お知らせ • Jun 26Syncona Limited to Report Q1, 2025 Results on Aug 15, 2024Syncona Limited announced that they will report Q1, 2025 results on Aug 15, 2024
お知らせ • Jun 21Syncona Limited to Report First Half, 2025 Results on Nov 14, 2024Syncona Limited announced that they will report first half, 2025 results on Nov 14, 2024
お知らせ • Jan 05Syncona Limited to Report Q3, 2024 Results on Feb 08, 2024Syncona Limited announced that they will report Q3, 2024 results on Feb 08, 2024
お知らせ • Nov 15Syncona Limited to Report Fiscal Year 2024 Results on Jun 20, 2024Syncona Limited announced that they will report fiscal year 2024 results on Jun 20, 2024
お知らせ • Oct 19Syncona Seeks to Buy Remaining Shares of Freeline TherapeuticsSyncona Limited (LSE:SYNC) that its investment manager has submitted a proposal to buy the shares of Freeline Therapeutics Holdings plc (NasdaqCM:FRLN) that it doesn't already own, and plans to start talks with the company over a potential deal. The U.K. healthcare company said Wednesday that it is offering to pay $5.00 for each American Depositary Share of Freeline, a 20% premium over the volume weighted average price of $4.16 between Oct. 4 and Oct. 16. Syncona, which currently owns approximately 57.9% of Freeline, said there isn't a guarantee that any deal will be agreed. Syncona shares at 10:30 GMT were up 0.20 pence, or 0.2%, at 126.20 pence.
お知らせ • Jun 29Syncona Limited to Report First Half, 2024 Results on Nov 16, 2023Syncona Limited announced that they will report first half, 2024 results on Nov 16, 2023
お知らせ • Jun 28Syncona Limited, Annual General Meeting, Aug 01, 2023Syncona Limited, Annual General Meeting, Aug 01, 2023, at 09:30 Coordinated Universal Time. Location: Citco Fund Services (Guernsey) Limited, Frances House, Sir William Place, St Peter Port, Guernsey GY1 1GX Guernsey United Kingdom Agenda: To consider The Directors must lay the annual audited accounts for the financial year ended 31 March 2023 and the reports of the Directors and Auditors before the Shareholders and the Shareholders will be asked to receive and consider the financial statements and the reports; to consider Shareholders will be asked to confirm the reappointment of Deloitte LLP (Guernsey Branch) as Auditors until the conclusion of the next annual general meeting due to be held in 2024 and to grant authority to the Board to determine their remuneration; and to transact such other business matter.
お知らせ • Dec 07Syncona Limited to Report Q3, 2023 Results on Feb 07, 2023Syncona Limited announced that they will report Q3, 2023 results on Feb 07, 2023
お知らせ • Aug 09Syncona Limited to Report Q1, 2023 Results on Aug 16, 2022Syncona Limited announced that they will report Q1, 2023 results on Aug 16, 2022
お知らせ • Aug 03Syncona Limited Approves Appointment of Julie Cherrington and Cristina Csimma as DirectorSyncona Limited at the AGM held on June 30, 2022 approved the appointment of Julie Cherrington as a Director and Cristina Csimma as a Director.
お知らせ • Jul 15Syncona Limited to Report First Half, 2023 Results on Nov 17, 2022Syncona Limited announced that they will report first half, 2023 results on Nov 17, 2022
お知らせ • Jul 01Syncona Limited, Annual General Meeting, Aug 02, 2022Syncona Limited, Annual General Meeting, Aug 02, 2022, at 09:30 Coordinated Universal Time. Location: Citco Fund Services (Guernsey) Limited, Arnold House St Julian’s Avenue, St Peter Port Guernsey United Kingdom Agenda: To consider that the Annual Audited Financial Statements of the Company for the year ended 31 March 2022, together with the reports of the Directors and Auditors therein, be received and considered; to consider that Deloitte LLP (Guernsey Branch) be re-appointed as Auditors until the conclusion of the next annual general meeting; to consider that the Board of Directors be authorized to determine the remuneration of the Auditors; to consider that Melanie Gee be re-elected as a Director; to consider that Julie Cherrington be elected as a Director; and to consider other matters.
お知らせ • Apr 01Syncona Limited to Report Fiscal Year 2022 Results on Jun 16, 2022Syncona Limited announced that they will report fiscal year 2022 results on Jun 16, 2022
お知らせ • Feb 12Syncona Limited Appoints Richard Francis as Chief Executive OfficerSyncona Limited appointed of Richard Francis, former Chief Executive of Sandoz and former member of Novartis Executive Committee, as Chief Executive Officer.
お知らせ • Feb 11Syncona Limited Decides to Reduce Its Overall Headcount by Approximately 20%Syncona Limited announced took decisive action in First Quarter 2021 to reduce its overall headcount by approximately 20%, realising cost savings, on an annualised basis, of approximately $15 million once the operational changes are fully implemented.
お知らせ • Dec 23Syncona Limited Appoints Virginia Holmes as A Non-Executive Director with Effect from 1 January 2021Syncona Ltd. announced the appointment of Virginia Holmes as a Non-Executive Director with effect from 1 January 2021.
お知らせ • Nov 19Syncona Limited Does Not Declare DividendDuring the period ended 30 September 2020, the Syncona Limited did not declare or pay a dividend (30 September 2019: £15,208,113, 31 March 2020: £15,208,113). The Directors believe that it is no longer appropriate for the Group to pay a dividend.
お知らせ • Nov 03Syncona Ltd Announces Retirement of Ellen Strahlman as Non-Executive Director with Effect from November 2, 2020Syncona Ltd. announces retirement of Ellen Strahlman as Non-Executive Director with effect from November 2, 2020.